Milestones

Pioneering the Future of Colorectal Surgery

At Averto Medical, innovation is in our DNA. From our inception to groundbreaking clinical advancements, we have been on a mission to redefine post-colorectal surgery recovery. Here’s how we’ve made history:

2016
2016

The Vision Begins

Averto Medical is founded with a bold mission: to eliminate the need for routine diverting ostomies and revolutionize colorectal surgery with an advanced intraluminal protection system.

2019
2019

Breakthrough in Negative Pressure Technology

After years of intensive research and development, we pioneer a negative pressure fixation system, offering secure yet atraumatic protection for anastomoses.

2021
2021

First Preclinical Trials

Successful bench and animal studies validate the safety, efficacy, and potential of the ColoSeal ICD System, demonstrating significant reductions in anastomotic leakage risks.
2023
2023

Global Surgeon Collaboration

We expand our clinical partnerships, working closely with leading colorectal surgeons and institutions worldwide to optimize device performance and usability.
2024
2024

Regulatory Advancements & Clinical Trials

  • FDA Pre-Submission Meeting for the ColoSeal ICD System
  • Launch of pivotal RCT clinical trials to demonstrate superior patient outcomes
  • Expanded international studies to validate real-world surgical benefits
2025 & Beyond
2025 & Beyond

Shaping the Future

Our journey doesn’t stop here. We continue to innovate, refine, and expand, ensuring that every colorectal surgery patient has access to the best possible recovery solution.

Join the Future of Colorectal Surgery

We are reshaping the standard of care with proven innovation, global expertise, and a patient-first mindset. Stay tuned as we continue to push the boundaries of what’s possible in surgical recovery.<br>
Contact us to learn more about our mission and innovations today.

For more information about ColoSeal ICD System

Search...